Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision tag updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer version of the document.
    Difference
    0.0%
    Check dated 2026-06-09T01:30:43.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision stamp updated from v3.5.3 to v3.5.4, signaling a new version of the page's documentation. The change is a minor backend update rather than a substantive alteration to study details.
    Difference
    0.0%
    Check dated 2026-05-18T14:32:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The Sweden location entry in the study's locations list has been updated from Malmo to Malmö, correcting the city spelling in Skåne County. This preserves an accurate and searchable location for participants and records.
    Difference
    0.0%
    Check dated 2026-05-04T08:25:21.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new related publication (on CD8+ T cells in ankylosing spondylitis) is added to the study’s publications list. The site’s displayed release/version label is updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:51:12.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T04:58:39.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added a new publication reference: 'Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis' (Rheumatol Ther. 2026). Updated revision to v3.5.0 (from v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-22T10:31:35.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.